Friday, July 3, 2026

the Vaccine Alliance

April 24, 2026

HPV, malaria vaccines save one million African lives as funding shifts

As of 2024, HPV vaccines have averted nearly one million cervical cancer deaths in 29 African countries.

HPV vaccine
April 24, 2026

Gavi warns funding gaps threaten malaria, HPV vaccination programmes in Africa

Gavi said it planned to make malaria vaccines available to 50 million children across Africa by 2030.

Gavi, the Vaccine Alliance
April 24, 2026

Malaria vaccines expand across Africa as Gavi warns of funding issues

Malaria vaccination is expanding across Africa, with early results showing fewer severe cases and deaths, even as funding challenges threaten to slow progress.

Malaria vaccine
April 16, 2026

20 million measles deaths averted since 2000 in Africa: WHO

Measles vaccinations have saved nearly 20 million lives in Africa since 2000, and more than 500 million children have been protected through routine immunisation.

Children with measles
November 17, 2025

HPV vaccines averted over one million cervical cancer deaths: Gavi

The alliance noted that an estimated 86 million girls were now protected against the leading cause of cervical cancer.

HPV vaccine
October 15, 2025

FG launches campaign against vaccine-preventable diseases

The exercise is expected to be rolled out in two phases and four streams over a 10-day schedule.

Measles vaccination
September 4, 2025

World Bank, UNICEF, others rally to ensure success of Nigeria’s SWAp reform

Owen Smith, lead health specialist at the World Bank, said stronger public financial management (PFM) would be central to results.

Health workers attending to Covid-19 patient
August 13, 2025

Gavi pledges $3 million to boost immunisation in Kaduna

Gavi, the Vaccine Alliance, has announced a $3 million investment over the next two years to strengthen routine immunisation and primary healthcare in Kaduna.

July 12, 2025

Vaccine campaigns cut deaths globally by nearly 60%: Study

Vaccinations helped reduce cholera cases and deaths by 28 per cent and 36 per cent, respectively.

VACCINES